A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda.
Saved in:
| Title: | A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda. |
|---|---|
| Authors: | Kiene, Susan M. (AUTHOR), Miller, Amanda P. (AUTHOR), Ediau, Michael (AUTHOR), Tuhebwe, Doreen (AUTHOR), Sileo, Katelyn M. (AUTHOR), Naigino, Rose (AUTHOR), Hahn, Judith A. (AUTHOR), Reed, Elizabeth (AUTHOR), Anecho, Asha (AUTHOR), Mukasa, Barbara (AUTHOR), Lin, Chii‐Dean (AUTHOR), Wanyenze, Rhoda K. (AUTHOR), Tumwesigye, Nazarius Mbona (AUTHOR) |
| Source: | Addiction. Jan2026, Vol. 121 Issue 1, p94-107. 14p. |
| Subjects: | Motivational interviewing, Patient compliance, Men, Self-evaluation, Antiretroviral agents, Phospholipids, Research funding, Pilot projects, Statistical sampling, Food security, Behavior, HIV infections, Treatment effectiveness, Randomized controlled trials, Alcohol-induced disorders, Highly active antiretroviral therapy, Fishing, Odds ratio, Drugs, Confidence intervals |
| Geographic Terms: | Sub-Saharan Africa, Uganda |
| Abstract: | Aims: We assessed the feasibility and preliminary efficacy of a multilevel intervention (Kisoboka) to reduce high‐risk alcohol use and improve human immunodeficiency virus (HIV) treatment engagement among fisherfolk men in Uganda. Design: A parallel individually randomized controlled pilot trial with follow‐up at 3 and 6 months. Setting: Five HIV clinics near Ugandan fishing communities. Participants: 160 men (80 per arm), aged 18–50, living with HIV, reporting suboptimal antiretroviral therapy (ART) adherence and high‐risk alcohol use, enrolled between January 2021 and March 2022. Intervention: Kisoboka applies behavioral economic principles and motivational interviewing to address contextual determinants of alcohol use and suboptimal HIV treatment through counseling sessions, text reminders about savings and health goals, and a structural component of assistance setting up mobile money accounts and use of mobile money to receive work pay. The comparator arm (S&R) received only brief alcohol screening feedback, referrals for alcohol counseling and HIV treatment counseling. Measurements High‐risk alcohol use assessed via phosphatidylethanol (PEth) level at baseline and 6 months and Alcohol Use Disorders Identification Test ‐ Consumption (AUDIT‐C) (cutoff ≥9) at baseline, 3 and 6 months. Self‐reported ART adherence (≥90% versus <90%) assessed at baseline, 3 and 6 months. Secondary outcomes: number of days with ≥5 drinks in the prior 28 days and HIV viral load. We assessed intervention fidelity by audio recording and transcribing sessions, then coding a random 20% sample for fidelity to protocol elements. Findings Retention (92.5% completed all sessions) and fidelity (92.8–100% across sessions) were high. Relative to the comparator arm, PEth values decreased from baseline to 6‐month follow‐up in the Kisoboka arm [difference in change −126.87 ng/ml, 95% confidence interval (CI) = −264.29 to 10.55], which was a small effect size (adjusted time* arm interaction: d = 0.14). The proportion with AUDIT‐C ≥9 decreased more in the Kisoboka arm between baseline and 6 months (−26.01%, 95% CI = −36.09% to −15.93%), a medium effect size time*arm effect (d = 0.68). Kisoboka did not improve adherence but protected against declines in optimal adherence observed in the S&R arm (difference in change: 20.96%, 95% CI = 7.15% to 34.77%), which was a medium effect size time*arm effect (d = 0.51). Conclusions: The Kisoboka multilevel intervention to reduce high‐risk alcohol use appears to be feasible; it showed promising clinically meaningful small to medium size effects on reducing high‐risk alcohol use and protected against decreases in antiretroviral therapy adherence in a setting with strong contextual determinants of behavior. [ABSTRACT FROM AUTHOR] |
| Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 190304750 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kiene%2C+Susan+M%2E%22">Kiene, Susan M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miller%2C+Amanda+P%2E%22">Miller, Amanda P.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ediau%2C+Michael%22">Ediau, Michael</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tuhebwe%2C+Doreen%22">Tuhebwe, Doreen</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sileo%2C+Katelyn+M%2E%22">Sileo, Katelyn M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naigino%2C+Rose%22">Naigino, Rose</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hahn%2C+Judith+A%2E%22">Hahn, Judith A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Reed%2C+Elizabeth%22">Reed, Elizabeth</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Anecho%2C+Asha%22">Anecho, Asha</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mukasa%2C+Barbara%22">Mukasa, Barbara</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lin%2C+Chii‐Dean%22">Lin, Chii‐Dean</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wanyenze%2C+Rhoda+K%2E%22">Wanyenze, Rhoda K.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tumwesigye%2C+Nazarius+Mbona%22">Tumwesigye, Nazarius Mbona</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Addiction%22">Addiction</searchLink>. Jan2026, Vol. 121 Issue 1, p94-107. 14p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Motivational+interviewing%22">Motivational interviewing</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+compliance%22">Patient compliance</searchLink><br /><searchLink fieldCode="DE" term="%22Men%22">Men</searchLink><br /><searchLink fieldCode="DE" term="%22Self-evaluation%22">Self-evaluation</searchLink><br /><searchLink fieldCode="DE" term="%22Antiretroviral+agents%22">Antiretroviral agents</searchLink><br /><searchLink fieldCode="DE" term="%22Phospholipids%22">Phospholipids</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Pilot+projects%22">Pilot projects</searchLink><br /><searchLink fieldCode="DE" term="%22Statistical+sampling%22">Statistical sampling</searchLink><br /><searchLink fieldCode="DE" term="%22Food+security%22">Food security</searchLink><br /><searchLink fieldCode="DE" term="%22Behavior%22">Behavior</searchLink><br /><searchLink fieldCode="DE" term="%22HIV+infections%22">HIV infections</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+effectiveness%22">Treatment effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trials%22">Randomized controlled trials</searchLink><br /><searchLink fieldCode="DE" term="%22Alcohol-induced+disorders%22">Alcohol-induced disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Highly+active+antiretroviral+therapy%22">Highly active antiretroviral therapy</searchLink><br /><searchLink fieldCode="DE" term="%22Fishing%22">Fishing</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+ratio%22">Odds ratio</searchLink><br /><searchLink fieldCode="DE" term="%22Drugs%22">Drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Confidence+intervals%22">Confidence intervals</searchLink> – Name: SubjectGeographic Label: Geographic Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Sub-Saharan+Africa%22">Sub-Saharan Africa</searchLink><br /><searchLink fieldCode="DE" term="%22Uganda%22">Uganda</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Aims: We assessed the feasibility and preliminary efficacy of a multilevel intervention (Kisoboka) to reduce high‐risk alcohol use and improve human immunodeficiency virus (HIV) treatment engagement among fisherfolk men in Uganda. Design: A parallel individually randomized controlled pilot trial with follow‐up at 3 and 6 months. Setting: Five HIV clinics near Ugandan fishing communities. Participants: 160 men (80 per arm), aged 18–50, living with HIV, reporting suboptimal antiretroviral therapy (ART) adherence and high‐risk alcohol use, enrolled between January 2021 and March 2022. Intervention: Kisoboka applies behavioral economic principles and motivational interviewing to address contextual determinants of alcohol use and suboptimal HIV treatment through counseling sessions, text reminders about savings and health goals, and a structural component of assistance setting up mobile money accounts and use of mobile money to receive work pay. The comparator arm (S&R) received only brief alcohol screening feedback, referrals for alcohol counseling and HIV treatment counseling. Measurements High‐risk alcohol use assessed via phosphatidylethanol (PEth) level at baseline and 6 months and Alcohol Use Disorders Identification Test ‐ Consumption (AUDIT‐C) (cutoff ≥9) at baseline, 3 and 6 months. Self‐reported ART adherence (≥90% versus <90%) assessed at baseline, 3 and 6 months. Secondary outcomes: number of days with ≥5 drinks in the prior 28 days and HIV viral load. We assessed intervention fidelity by audio recording and transcribing sessions, then coding a random 20% sample for fidelity to protocol elements. Findings Retention (92.5% completed all sessions) and fidelity (92.8–100% across sessions) were high. Relative to the comparator arm, PEth values decreased from baseline to 6‐month follow‐up in the Kisoboka arm [difference in change −126.87 ng/ml, 95% confidence interval (CI) = −264.29 to 10.55], which was a small effect size (adjusted time* arm interaction: d = 0.14). The proportion with AUDIT‐C ≥9 decreased more in the Kisoboka arm between baseline and 6 months (−26.01%, 95% CI = −36.09% to −15.93%), a medium effect size time*arm effect (d = 0.68). Kisoboka did not improve adherence but protected against declines in optimal adherence observed in the S&R arm (difference in change: 20.96%, 95% CI = 7.15% to 34.77%), which was a medium effect size time*arm effect (d = 0.51). Conclusions: The Kisoboka multilevel intervention to reduce high‐risk alcohol use appears to be feasible; it showed promising clinically meaningful small to medium size effects on reducing high‐risk alcohol use and protected against decreases in antiretroviral therapy adherence in a setting with strong contextual determinants of behavior. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Addiction is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=190304750 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/add.70169 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 14 StartPage: 94 Subjects: – SubjectFull: Motivational interviewing Type: general – SubjectFull: Patient compliance Type: general – SubjectFull: Men Type: general – SubjectFull: Self-evaluation Type: general – SubjectFull: Antiretroviral agents Type: general – SubjectFull: Phospholipids Type: general – SubjectFull: Research funding Type: general – SubjectFull: Pilot projects Type: general – SubjectFull: Statistical sampling Type: general – SubjectFull: Food security Type: general – SubjectFull: Behavior Type: general – SubjectFull: HIV infections Type: general – SubjectFull: Treatment effectiveness Type: general – SubjectFull: Randomized controlled trials Type: general – SubjectFull: Alcohol-induced disorders Type: general – SubjectFull: Highly active antiretroviral therapy Type: general – SubjectFull: Fishing Type: general – SubjectFull: Odds ratio Type: general – SubjectFull: Drugs Type: general – SubjectFull: Confidence intervals Type: general – SubjectFull: Sub-Saharan Africa Type: general – SubjectFull: Uganda Type: general Titles: – TitleFull: A pilot randomized controlled trial of Kisoboka, a behavioral economic and motivational interviewing intervention to reduce high‐risk alcohol use and improve antiretroviral therapy adherence for men in Uganda. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kiene, Susan M. – PersonEntity: Name: NameFull: Miller, Amanda P. – PersonEntity: Name: NameFull: Ediau, Michael – PersonEntity: Name: NameFull: Tuhebwe, Doreen – PersonEntity: Name: NameFull: Sileo, Katelyn M. – PersonEntity: Name: NameFull: Naigino, Rose – PersonEntity: Name: NameFull: Hahn, Judith A. – PersonEntity: Name: NameFull: Reed, Elizabeth – PersonEntity: Name: NameFull: Anecho, Asha – PersonEntity: Name: NameFull: Mukasa, Barbara – PersonEntity: Name: NameFull: Lin, Chii‐Dean – PersonEntity: Name: NameFull: Wanyenze, Rhoda K. – PersonEntity: Name: NameFull: Tumwesigye, Nazarius Mbona IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 09652140 Numbering: – Type: volume Value: 121 – Type: issue Value: 1 Titles: – TitleFull: Addiction Type: main |
| ResultId | 1 |